欧盟中国商会声明：反对欧委会IPI下排除中企参与医疗器械公共采购

Core Viewpoint - The European Union Chamber of Commerce in China opposes the European Commission's decision to exclude Chinese companies from participating in public procurement for medical devices under the International Procurement Instrument (IPI) [1] Group 1: EU Commission's Decision - On June 20, the European Commission announced the exclusion of Chinese companies from public procurement related to the IPI, stating that products and components from China must not exceed 50% in winning bids [1] - The EU Chamber criticizes this unilateral protectionist measure and claims it is an unfair discriminatory action against Chinese enterprises [1] Group 2: Chamber's Response - The EU Chamber argues that the findings of the IPI investigation are not fair, asserting that the conclusion regarding the exclusion or discrimination of EU-manufactured medical devices in China's public procurement market does not reflect reality [1] - The Chamber expresses disappointment over the EU's hasty unilateral measures, especially given the ongoing discussions between China and the EU regarding the Government Procurement Agreement (GPA) and public procurement issues [1] Group 3: Call for Fair Treatment - The EU Chamber condemns the discriminatory and exclusionary measures against Chinese products and suppliers, emphasizing the negative impact on trade and investment relations between China and the EU in the medical field [1] - The Chamber urges the EU to immediately cease these erroneous practices and provide a fair, just, and non-discriminatory business environment for Chinese companies in the medical sector in Europe [1]